These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Towards new TB vaccines: What are the challenges? Dockrell HM Pathog Dis; 2016 Jun; 74(4):ftw016. PubMed ID: 26960944 [TBL] [Abstract][Full Text] [Related]
4. Successes and failures in human tuberculosis vaccine development. Zenteno-Cuevas R Expert Opin Biol Ther; 2017 Dec; 17(12):1481-1491. PubMed ID: 28927311 [TBL] [Abstract][Full Text] [Related]
5. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis. Xing Z; Charters TJ Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008 [TBL] [Abstract][Full Text] [Related]
6. TB vaccines in clinical development. Ginsberg AM; Ruhwald M; Mearns H; McShane H Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S16-20. PubMed ID: 27470538 [TBL] [Abstract][Full Text] [Related]
7. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion. Sierra VG Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design. Ernst JD Cell Host Microbe; 2018 Jul; 24(1):34-42. PubMed ID: 30001523 [TBL] [Abstract][Full Text] [Related]
9. Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines. Scriba TJ; Kaufmann SH; Henri Lambert P; Sanicas M; Martin C; Neyrolles O J Infect Dis; 2016 Sep; 214(5):659-64. PubMed ID: 27247343 [TBL] [Abstract][Full Text] [Related]
10. Novel approaches to preclinical research and TB vaccine development. Walker KB; Guo M; Guo Y; Poecheim J; Velmurugan K; Schrager LK Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S12-5. PubMed ID: 27452413 [TBL] [Abstract][Full Text] [Related]
11. Recombinant live vaccine candidates against tuberculosis. Kaufmann SH; Gengenbacher M Curr Opin Biotechnol; 2012 Dec; 23(6):900-7. PubMed ID: 22483201 [TBL] [Abstract][Full Text] [Related]
14. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine. Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B Front Immunol; 2018; 9():2371. PubMed ID: 30386336 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial. Vuola JM; Ristola MA; Cole B; Järviluoma A; Tvaroha S; Rönkkö T; Rautio O; Arbeit RD; von Reyn CF AIDS; 2003 Nov; 17(16):2351-5. PubMed ID: 14571187 [TBL] [Abstract][Full Text] [Related]
16. Prospects for elimination of childhood tuberculosis: the role of new vaccines. Hatherill M Arch Dis Child; 2011 Sep; 96(9):851-6. PubMed ID: 21450742 [TBL] [Abstract][Full Text] [Related]
18. Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost? Khademi F; Derakhshan M; Yousefi-Avarvand A; Tafaghodi M; Soleimanpour S Expert Rev Vaccines; 2018 Jan; 17(1):31-44. PubMed ID: 29148853 [TBL] [Abstract][Full Text] [Related]
19. The current status, challenges, and future developments of new tuberculosis vaccines. Gong W; Liang Y; Wu X Hum Vaccin Immunother; 2018 Jul; 14(7):1697-1716. PubMed ID: 29601253 [TBL] [Abstract][Full Text] [Related]
20. Novel tuberculosis vaccines on the horizon. Parida SK; Kaufmann SH Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]